We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

169 hedge funds and large institutions have $655M invested in Ariad Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 44

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

0% more funds holding

Funds holding: 169 → 169 (0)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

17% less capital invested

Capital invested by funds: $790M → $655M (-$135M)

23% less call options, than puts

Call options by funds: $20.5M | Put options by funds: $26.5M

Holders
169
Holders Change
–
Holders Change %
0%
% of All Funds
4.9%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
25
Increased
61
Reduced
44
Closed
24
Calls
$20.5M
Puts
$26.5M
Net Calls
-$6.01M
Net Calls Change
-$11M

Top Buyers

Rank Fund Capital Flow
1
CCI
Columbus Circle Investors
+$13.6M
2
PC
PointState Capital
New York
+$10.5M
3
DFO
Duquesne Family Office
New York
+$9.61M
4
O
OppenheimerFunds
New York
+$9.46M
5
Millennium Management
Millennium Management
New York
+$8.33M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$32.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$22M
3
Renaissance Technologies
Renaissance Technologies
New York
-$18.4M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$14.2M
5
Norges Bank
Norges Bank
Norway
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
126
Ameritas Investment Partners
Nebraska
$80K – – –
N
127
Nuveen
North Carolina
$72K – – –
ID
128
Integral Derivatives
New York
$66K -$17.5K -3,000 -20%
SCM
129
Stevens Capital Management
Pennsylvania
$64K -$115K -19,759 -62%
Canada Life
130
Canada Life
Manitoba, Canada
$57K – – –
FDCC
131
Foster Dykema Cabot & Co
Massachusetts
$55K – – –
BNP Paribas Financial Markets
132
BNP Paribas Financial Markets
France
$53.3K +$18.1K +3,098 +46%
US Bancorp
133
US Bancorp
Minnesota
$47K +$7.44K +1,274 +18%
Citigroup
134
Citigroup
New York
$43K -$441K -75,442 -90%
Teacher Retirement System of Texas
135
Teacher Retirement System of Texas
Texas
$35K – – –
Bank of Montreal
136
Bank of Montreal
Ontario, Canada
$31K -$117K -20,000 -78%
PNC Financial Services Group
137
PNC Financial Services Group
Pennsylvania
$30K – – –
EWM
138
Edge Wealth Management
New York
$30K +$14.6K +2,500 +83%
RIA
139
Regal Investment Advisors
Michigan
$27K – – –
BlackRock
140
BlackRock
New York
$26K – – –
SO
141
STRS Ohio
Ohio
$22K +$23.4K +4,000 New
RAM
142
Riggs Asset Management
Pennsylvania
$18K +$19.3K +3,300 New
Schroder Investment Management Group
143
Schroder Investment Management Group
United Kingdom
$16.2K – – –
CPA
144
Cowen Prime Advisors
New York
$10K -$5.55K -950 -34%
RFC
145
Russell Frank Company
Washington
$10K +$10.5K +1,802 New
Dimensional Fund Advisors
146
Dimensional Fund Advisors
Texas
$9K -$1.75K -300 -15%
OIA
147
Optimum Investment Advisors
Illinois
$8K -$292 -50 -3%
Fifth Third Bancorp
148
Fifth Third Bancorp
Ohio
$8K – – –
CCMH
149
Cornerstone Capital Management Holdings
New York
$7K +$7.59K +1,300 New
MCM
150
Manchester Capital Management
Vermont
$5K – – –
4 5
6
7 8

ARIA Hedge Fund Activity: Q3 2014 in Review

169 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2014, worth a combined $655M — down 17% from $790M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ARIA positions and 24 closed out — a net gain of 1 holder — while 61 added to existing stakes and 44 trimmed.

The largest buyer was Columbus Circle Investors, opening a new position worth an estimated $13.6M. The largest seller was Franklin Resources, exiting entirely with an estimated $32.1M sold.

  • 169 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $655M of Ariad Pharmaceuticals Inc stock for Q3 2014, down 17% quarter-over-quarter.
  • 25 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2014 and 24 closed out, a net change of +1 holder.
  • The largest Ariad Pharmaceuticals Inc buyer in Q3 2014 was Columbus Circle Investors, an estimated $13.6M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q3 2014 was Franklin Resources, an estimated $32.1M sold.

Based on aggregated 13F filings for Q3 2014.